Evidence map›Paper›PMID 37173691›Full record

ArticleBMC psychiatry2023

Community-based rehabilitation interventions on quality of care for people with schizophrenia in China (CRISC): study protocol for a cluster-randomized controlled trial.

Ruoxi Ding, Miaomiao Zhao, Yanshang Wang, Ming Wang, Dan Guo, Xiao Liu, Lei Wang, Wentao Wei, Wei Zhang, Ping He

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ruoxi Ding *China Center for Health and Development Studies, Peking University, Beijing, China.
Miaomiao Zhao *Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanshang WangSchool of Public Health, Peking University, Beijing, China.
Ming WangSchool of Public Health, Peking University, Beijing, China.
Dan GuoChina Center for Health and Development Studies, Peking University, Beijing, China.
Xiao LiuSchool of Management, Weifang Medical University, Weifang, Shandong province, China.
Lei WangWeifang Kuiwen District Medical care and Health Industry Development Center, Weifang, Shandong province, China.
Wentao WeiWeifang City Hanting District Gudi street Pozi hospital, Weifang, Shandong province, China.
Wei ZhangWeicheng District health comprehensive law enforcement brigade, Weifang, Shandong province, China.
Ping HeChina Center for Health and Development Studies, Peking University, Beijing, China. phe@pku.edu.cn.
Peking University · CNWeifang Medical University · CNShanghai Hospital Development Center · CNWeichai Power (China) · CNWeifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInternational consensus shows that community-based rehabilitation (CBR) service is an effective way to improve functioning and negative symptoms and address the treatment gap for schizophrenia. Rigorous trials are needed in China to demonstrate effective and scalable CBR interventions to significantly improve outcomes for people with schizophrenia and to provide evidence of the economic benefits. The objectives of this trial are to examine the effectiveness of CBR as an adjunct to test the usual facility-cased care (FBC) in comparison to FBC alone in improving a range of outcomes in people with schizophrenia and their caregivers.

methodsThis trial is a cluster randomized controlled trial design in China. The trial will be conducted at three districts of Weifang city, Shandong province. Eligible participants will be identified from the psychiatric management system where community-dwelling patients with schizophrenia have been registered. Participants will be recruited after providing informed consent. 18 sub-districts will be randomly allocated in a 1:1 ratio to facility-based care (FBC) plus CBR (intervention arm) or FBC alone (control arm). The structured CBR intervention will be delivered by trained psychiatric nurses or community health workers. We aim to recruit 264 participants. The primary outcomes include symptoms of schizophrenia, personal and social function, quality of life, family burden of caring, etc. The study will be conducted according to good ethical practice, data analysis and reporting guidelines. DISCUSSION: If the hypothesized clinical benefit and cost-effectiveness of CBR intervention are confirmed, this trial will provide significant implications for policy makers and practitioners to scale up rehabilitation services, as well as for people with schizophrenia and their family to promote recovery and social inclusion, and to alleviate the burden of care.

trial registrationChinese Clinical Trial Registry (ChiCTR2200066945). Registered December 22, 2022.

Indexed as

SchizophreniaChinaCost-Benefit AnalysisHumansQuality of Health CareQuality of LifeRandomized Controlled Trials as Topic

Identifiers

PMID37173691
PMCPMC10176931
OpenAlexW4376642271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.